Loading
Life sciences · Observational Study
ClinicalTrials.gov · October 20, 2026
No summary has been generated for this record yet. What follows is drawn from its source metadata only.
Observational Study.
No findings were extractable from the material analysed.
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
The source did not state who this applies to in practice.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
This record has not been graded across any dimension yet. Treat the label above as provisional and read the source.
What is missing. This record has no bottom line, key findings, reported figures, evidence dimensions. That is a gap in the analysis, not a judgement about the study.
Registry record from ClinicalTrials.gov (NCT00898508). This is a study registration, not published results. Lead sponsor: City of Hope Medical Center. Recruitment status: COMPLETED. Study type: OBSERVATIONAL. Enrollment: 563 participants (ACTUAL). Conditions: Breast Cancer. Interventions: GENETIC: gene expression analysis; GENETIC: mutation analysis; GENETIC: proteomic profiling; GENETIC: reverse transcriptase-polymerase chain reaction; OTHER: fluorescent antibody technique; OTHER: immunohistochemistry staining method; OTHER: laboratory biomarker analysis; OTHER: liquid chromatography; OTHER: mass spectrometry; OTHER: medical chart review; PROCEDURE: quality-of-life assessment. Primary outcome measures: Establishment of a specimen bank , 5 Years of specimen collection; Ability of the quantitative real-time reverse-transcriptase PCR (qRT-PCR) to distinguish between biopsy benign and malignant results , 5 years; Ability of the qRT-PCR to predict treatment response , 5 years; Ability of the qRT-PCR to predict relapse , 5 years; Ability of the qRT-PCR to perform as an independent prognostic factor , 5 years. Brief summary: RATIONALE: Collecting and storing samples of blood and tumor tissue from patients with cancer to test in the laboratory may help the study of cancer in the future. PURPOSE: This clinical trial is studying blood and tumor tissue samples in women with invasive breast cancer, ductal carcinoma in situ, lobular carcinoma in situ, or benign breast disease.